Quarterly report pursuant to Section 13 or 15(d)

CAPITAL STOCK (Details Narrative)

v3.5.0.2
CAPITAL STOCK (Details Narrative) - USD ($)
 9 Months Ended
May 11, 2016
Mar. 17, 2016
Jan. 22, 2016
Jan. 09, 2016
Dec. 29, 2015
Dec. 11, 2015
Jun. 30, 2016
Jun. 30, 2015
Sep. 30, 2015
Value of stock issued for acquisitions             $ 2,061,136    
Restricted stock issued             660,757    
Stock based compensation expense issued for services             $ 1,237,064 $ 506,928  
Restricted Common Stock [Member]                  
Description of vesting rights      

50% of these shares vest on the January 9, 2017 and the remaining 50% vest on January 9, 2018.

          
Warrants [Member]                  
Value of stock issued for exercise of warrants $ 12,501       $ 13,540        
Number of shares issued 8,334       6,944        
Exercise price (in dollars per share) $ 1.50       $ 1.95   $ 4.71   $ 4.75
Mr. Dr. Irach Taraporewala [Member]                  
Restricted stock issued           120,000      
Sam Backenroth [Member] | Restricted Common Stock [Member]                  
Number of shares granted       130,000          
Dr. Jason Slakter [Member] | Restricted Common Stock [Member]                  
Number of shares granted       350,358          
Consultant [Member] | Restricted Common Stock [Member]                  
Number of shares issued for services   35,000 25,399